Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Syros Pharmaceuticals, Inc. | syrs-20171231x10k.htm |
| EX-32.2 - EX-32.2 - Syros Pharmaceuticals, Inc. | syrs-20171231ex322362f7f.htm |
| EX-32.1 - EX-32.1 - Syros Pharmaceuticals, Inc. | syrs-20171231ex321693e83.htm |
| EX-31.2 - EX-31.2 - Syros Pharmaceuticals, Inc. | syrs-20171231ex312f28248.htm |
| EX-31.1 - EX-31.1 - Syros Pharmaceuticals, Inc. | syrs-20171231ex311170e1a.htm |
| EX-21.1 - EX-21.1 - Syros Pharmaceuticals, Inc. | syrs-20171231ex2115c79cd.htm |
| EX-10.22 - EX-10.22 - Syros Pharmaceuticals, Inc. | syrs-20171231ex1022a272b.htm |
| EX-10.13 - EX-10.13 - Syros Pharmaceuticals, Inc. | syrs-20171231ex1013a0189.htm |
| EX-4.4 - EX-4.4 - Syros Pharmaceuticals, Inc. | syrs-20171231ex447401680.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
1. |
Registration Statement (Form S-8 No. 333-212363) pertaining to the 2012 Equity Incentive Plan, 2016 Stock Incentive Plan, and 2016 Employee Stock Purchase Plan of Syros Pharmaceuticals, Inc., |
|
2. |
Registration Statement (Form S-8 No. 333-216821) pertaining to the 2016 Stock Incentive Plan and 2016 Employee Stock Purchase Plan of Syros Pharmaceuticals, Inc., |
|
3. |
Registration Statement (Form S-3 No. 333-222634) of Syros Pharmaceuticals, Inc., |
|
4. |
Registration Statement (Form S-3 No. 333-219369) of Syros Pharmaceuticals, Inc., and |
|
5. |
Registration Statement (Form S-1 No. 333-218012) of Syros Pharmaceuticals, Inc.; |
of our report dated March 12, 2018, with respect to the consolidated financial statements of Syros Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2017.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 12, 2018